|
1
|
Sun J, Wu Q, Wei Y, Zhao W, Lv H, Peng W, Zheng J, Chen Y, Wang Z, Pan Y, Xue Y. Agaricus bisporus-Derived Glucosamine Hydrochloride Regulates VEGF through BMP Signaling to Promote Zebrafish Vascular Development and Impairment Repair. Life (Basel) 2023; 13:2330. [PMID: 38137931 PMCID: PMC10745105 DOI: 10.3390/life13122330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 12/01/2023] [Accepted: 12/05/2023] [Indexed: 12/24/2023] Open
Abstract
Glucosamine hydrochloride (GAH) is a natural component of glycoproteins present in almost all human tissues and participates in the construction of human tissues and cell membranes. GAH has a wide range of biological activities, particularly in anti-inflammatory and osteogenic damage repair. At present, little is known about how GAH functions in angiogenesis. To determine the role of GAH on vascular development and impairment repair, we used the inhibitors VRI, DMH1, and dorsomorphin (DM) to construct vascular-impaired models in Tg(kdrl: mCherry) transgenic zebrafish. We then treated with GAH and measured its repair effects on vascular impairment through fluorescence intensity, mRNA, and protein expression levels of vascular-specific markers. Our results indicate that GAH promotes vascular development and repairs impairment by regulating the vascular endothelial growth factor (VEGF) signaling pathway through modulation of bone morphogenetic protein (BMP) signaling. This study provides an experimental basis for the development of GAH as a drug to repair vascular diseases.
Collapse
Affiliation(s)
- Jiarui Sun
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Qici Wu
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Yuxin Wei
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Wei Zhao
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Haokun Lv
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Wei Peng
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Jiayi Zheng
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Yixuan Chen
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Zhengsen Wang
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Yutian Pan
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| | - Yu Xue
- The Engineering Technological Center of Mushroom Industry, Minnan Normal University, Zhangzhou 363000, China; (J.S.); (Q.W.); (Y.W.); (W.Z.); (H.L.); (W.P.); (J.Z.); (Y.C.); (Z.W.)
- Fujian Fungal Active Substance Engineering Technology Center, Zhangzhou 363000, China
| |
Collapse
|
|
2
|
Zhou C, Zhang Y, Yang S, Ye Z, Wu Q, Liu M, He P, Zhang Y, Qin X. Habitual glucosamine use, APOE genotypes, and risk of incident cause-specific dementia in the older population. Alzheimers Res Ther 2023; 15:152. [PMID: 37689747 PMCID: PMC10492372 DOI: 10.1186/s13195-023-01295-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Accepted: 08/24/2023] [Indexed: 09/11/2023]
Abstract
BACKGROUND The relationship of glucosamine use with incident dementia in the older population remains uncertain. We aimed to evaluate the longitudinal association between habitual glucosamine supplement and the risk of cause-specific dementia and examine the possible effect modifiers on this association. METHODS The study included 214,945 participants over the age of 60 who had available information on glucosamine use and did not have dementia at baseline in the UK Biobank. The APOE genotypes were determined by a combination variant of rs429358 and rs7412. The primary outcome was incident vascular dementia, incident Alzheimer's disease, and incident frontotemporal dementia, respectively. RESULTS Over a median follow-up duration of 12 years, 1039, 1774, and 122 participants developed vascular dementia, Alzheimer's disease, and frontotemporal dementia, respectively. Overall, habitual glucosamine use was significantly associated with a lower risk of incident vascular dementia (adjusted HR, 0.82; 95%CI, 0.70-0.96), but not significantly associated with incident Alzheimer's disease (adjusted HR, 1.02; 95%CI, 0.92-1.14) and incident frontotemporal dementia (adjusted HR, 0.95; 95%CI, 0.63-1.43). Moreover, the inverse association between habitual glucosamine use and incident vascular dementia was more pronounced in participants with concomitant supplement of calcium (P-interaction = 0.011), and those without concomitant supplement of zinc (P-interaction = 0.018). However, APOE ε4 dosage and baseline cognitive function did not significantly modify the relationships of glucosamine use with incident vascular dementia or Alzheimer's disease (All P-interactions > 0.05). CONCLUSIONS Regardless of APOE genotypes and baseline cognitive function, habitual glucosamine use was significantly inversely associated with incident vascular dementia in the older population.
Collapse
Affiliation(s)
- Chun Zhou
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Yanjun Zhang
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Sisi Yang
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Ziliang Ye
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Qimeng Wu
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Mengyi Liu
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Panpan He
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Yuanyuan Zhang
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
| | - Xianhui Qin
- National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
| |
Collapse
|
|
3
|
Cho JM, Koh JH, Kim SG, Lee S, Kim Y, Cho S, Kim K, Kim YC, Han SS, Lee H, Lee JP, Joo KW, Lim CS, Kim YS, Kim DK, Park S. Causal Effect of Chondroitin, Glucosamine, Vitamin, and Mineral Intake on Kidney Function: A Mendelian Randomization Study. Nutrients 2023; 15:3318. [PMID: 37571255 PMCID: PMC10421197 DOI: 10.3390/nu15153318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Revised: 07/23/2023] [Accepted: 07/24/2023] [Indexed: 08/13/2023] Open
Abstract
The causal effects of chondroitin, glucosamine, and vitamin/mineral supplement intake on kidney function remain unknown, despite being commonly used. We conducted a two-sample summary-level Mendelian randomization (MR) analysis to test for causal associations between regular dietary supplement intake and kidney function. Genetic instruments for chondroitin, glucosamine, and vitamin/mineral supplement intake were obtained from a genome-wide association study of European ancestry. Summary statistics for the log-transformed estimated glomerular filtration rate (log-eGFR) were provided by the CKDGen consortium. The multiplicative random-effects inverse-variance weighted method showed that genetically predicted chondroitin and glucosamine intake was causally associated with a lower eGFR (chondroitin, eGFR change beta = -0.113%, standard error (SE) = 0.03%, p-value = 2 × 10-4; glucosamine, eGFR change beta = -0.240%, SE = 0.035%, p-value = 6 × 10-12). However, a genetically predicted vitamin/mineral supplement intake was associated with a higher eGFR (eGFR change beta = 1.426%, SE = 0.136%, p-value = 1 × 10-25). Validation analyses and pleiotropy-robust MR results for chondroitin and vitamin/mineral supplement intake supported the main results. Our MR study suggests a potential causal effect of chondroitin and glucosamine intake on kidney function. Therefore, clinicians should carefully monitor their long-term effects.
Collapse
Affiliation(s)
- Jeong-Min Cho
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
| | - Jung-Hun Koh
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
| | - Seong-Geun Kim
- Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul 01757, Republic of Korea
| | - Soojin Lee
- Department of Internal Medicine, Uijeongbu Eulji University Medical Center, Uijeongbu 11759, Republic of Korea
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
| | - Yaerim Kim
- Department of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Republic of Korea
| | - Semin Cho
- Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong 14353, Republic of Korea
| | - Kwangsoo Kim
- Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul 03080, Republic of Korea
| | - Yong-Chul Kim
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
| | - Seung-Seok Han
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
- Kidney Research Institute, Seoul National University, Seoul 03080, Republic of Korea
| | - Hajeong Lee
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
| | - Jung-Pyo Lee
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
- Kidney Research Institute, Seoul National University, Seoul 03080, Republic of Korea
- Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul 07061, Republic of Korea
| | - Kwon-Wook Joo
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
- Kidney Research Institute, Seoul National University, Seoul 03080, Republic of Korea
| | - Chun-Soo Lim
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
- Kidney Research Institute, Seoul National University, Seoul 03080, Republic of Korea
- Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul 07061, Republic of Korea
| | - Yon-Su Kim
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
- Kidney Research Institute, Seoul National University, Seoul 03080, Republic of Korea
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
| | - Dong-Ki Kim
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
- Kidney Research Institute, Seoul National University, Seoul 03080, Republic of Korea
| | - Sehoon Park
- Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; (J.-M.C.)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul 07061, Republic of Korea
| |
Collapse
|
|
4
|
Wang Z, Wang J, Zhang L, Meng X, Dai G, Wang Q. Diacerein plus glucosamine hydrochloride improves the safety and efficacy and inhibit inflammatory factors in the treatment of knee osteoarthritis. Am J Transl Res 2023; 15:548-555. [PMID: 36777840 PMCID: PMC9908446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2022] [Accepted: 12/22/2022] [Indexed: 02/14/2023]
Abstract
OBJECTIVES The aim of this study is to elucidate the safety and efficacy of diacerein (DIA) plus glucosamine hydrochloride (GlcN·HCl) in the treatment of knee osteoarthritis (KOA) and their effect on inflammatory factors (IFs). METHODS Retrospectively, 116 KOA patients admitted between August 2018 and August 2021 were selected. Among them, 55 cases received DIA monotherapy (control group, Con) and 61 cases received DIA + GlcN·HCl (observation group, Obs). The efficacy, safety, scores of Lequesne Index, and Visual Analogue Scale (VAS), as well as the levels of IFs of the two groups were observed and compared. Further, Cox regression was used to perform an in-depth analysis of factors influencing the occurrence of complications in patients with KOA. RESULTS The analyses revealed a higher overall response rate and a lower adverse event rate in the Obs group compared with the Con group, with statistical significance. Decreased scores of Lequesne Index and VAS and levels of IFs were determined in the Obs after treatment, which were all significantly lower compared with those of the Con. Cox regression analysis identified that TNF-α, IL-1β, hs-CRP, and treatment mode affected the occurrence of complications in KOA patients. CONCLUSIONS DIA + GlcN·HCl can significantly inhibit the inflammation level in KOA, with definite curative effects and a favorable safety profile.
Collapse
Affiliation(s)
- Zhiyu Wang
- South China Hospital of Shenzhen UniversityShenzhen 518000, Guangdong, P. R. China
| | - Jianing Wang
- Gastrointestinal Surgery, Beidahuang Group General HospitalHarbin 150088, Heilongjiang, P. R. China
| | - Li Zhang
- Department of Orthopedics, Rehabilitation Hospital, National Research Center for Rehabilitation Technical AidsBeijing 102676, P. R. China
| | - Xiangning Meng
- Peking University First HospitalBeijing 100034, P. R. China
| | - Guangming Dai
- Department of Orthopedic Medicine, Third Affiliated Hospital of Inner Mongolia MedicalInner Mongolia 010050, P. R. China
| | - Quan Wang
- Inner Mongolia Bailige Medical Science and Technology Co., Ltd.Inner Mongolia 010010, P. R. China
| |
Collapse
|
|
5
|
Comprehensive Rehabilitation Therapy Plus Glucosamine Hydrochloride for Exercise-Induced Knee Injuries and the Effect on Knee Function of Patients. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2022; 2022:8120458. [PMID: 35795281 PMCID: PMC9252625 DOI: 10.1155/2022/8120458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Revised: 05/23/2022] [Accepted: 05/28/2022] [Indexed: 11/18/2022]
Abstract
Objective To assess the application value of comprehensive rehabilitation therapy plus glucosamine hydrochloride for exercise-induced knee injuries and its effect on knee function. Methods A total of 96 patients with an exercise-induced knee injury who were admitted to our hospital from February 2019 to February 202 were recruited and assigned at a ratio of 1 : 1 with matched general information to a control group (n = 45) or an experimental group (n = 51). Both groups of patients received comprehensive rehabilitation therapy, and the patients in the experimental group were daily given additional glucosamine hydrochloride tablets for 8 weeks. Results The experimental group showed a higher treatment efficacy than the control group (P < 0.001). After the treatment, the VAS scores and C-reactive protein of the two groups showed a decline, with a lower result in the experimental group than in the control group (P < 0.001). The Lysholm knee scores were increased in the two groups after the treatment, and the experimental group had a higher score (P < 0.001). After the treatment, patients of both groups showed reduced five-times-sit-to-stand-test (FTSST) results, with a better outcome obtained in the experimental group (P < 0.001). Conclusion Comprehensive rehabilitation therapy plus glucosamine hydrochloride effectively improves the clinical efficacy of exercise-induced knee joint injuries and enhances the knee joint rehabilitation of the patients.
Collapse
|
|
6
|
Chen TY, Sun D, Lin WS, Lin YL, Chao YM, Chen SY, Chen YR, Wu YL. Glucosamine regulation of fibroblast growth factor 21 expression in liver and adipose tissues. Biochem Biophys Res Commun 2020; 529:714-719. [PMID: 32736697 DOI: 10.1016/j.bbrc.2020.06.070] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Accepted: 06/15/2020] [Indexed: 10/23/2022]
Abstract
Obesity is associated with metabolic disorders. Fibroblast growth factor 21 (FGF21) has been recognized as important in metabolism. Glucosamine (GLN) has been demonstrated to perform diverse beneficial functions. This study aimed to reveal whether and how GLN would modulate FGF21 production in relation to metabolism. With in vivo model of normal diet (ND) and high-fat diet (HFD) mice receiving GLN injection and in vitro model of mouse AML12 liver cells and differentiated 3T3L1 adipocytes challenged with GLN, GLN appeared to improve the glucose metabolism in HFD and ND mice and to elevate FGF21 protein expression in HFD liver and to increase both FGF21 protein and mRNA levels in WAT from HFD and ND mice and it also upregulated FGF21 expression in both AML12 and differentiated 3T3L1 cells. By using inhibitors against various signaling pathways, p38, Akt, NF-κB, and PKA appeared potentially involved in GLN-mediated FGF21 production in AML12 cells; GLN was able to mediate activation of NF-κB, p38 or PKA/CREB signaling. Our accumulated findings suggest that GLN may potentially improve the metabolic performance by inducing FGF21 production in liver and adipose tissues and such induction in liver cells may act in part due to GLN induction of the NF-κB, p38 and PKA pathways.
Collapse
Affiliation(s)
- Ting-Yu Chen
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
| | - David Sun
- Department of Obstetrics and Gynecology, Cheng Hsin General Hospital, Taipei, Taiwan
| | - Wei-Shen Lin
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
| | - Yi-Ling Lin
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
| | - Yu-Ming Chao
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
| | - Shan-Yu Chen
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
| | - Yun-Ru Chen
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
| | - Yuh-Lin Wu
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
| |
Collapse
|
|
7
|
Khanna A, Das SS, Smina TP, Thomas JV, Kunnumakkara AB, Maliakel B, Krishnakumar IM, Mohanan R. Curcumagalactomannoside/Glucosamine Combination Improved Joint Health Among Osteoarthritic Subjects as Compared to Chondroitin Sulfate/Glucosamine: Double-Blinded, Randomized Controlled Study. J Altern Complement Med 2020; 26:945-955. [PMID: 32678677 DOI: 10.1089/acm.2020.0128] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
Objective: A combination of curcumagalactomannosides (CGM) (400 mg) with glucosamine hydrochloride (GLN) (500 mg) was evaluated against a standard dietary supplement combination chondroitin sulfate (CHN) (415 mg)/GLN (500 mg) for their effectiveness in alleviating the pain and symptoms among osteoarthritic subjects. Design: Randomized, double-blinded and active-controlled study. Settings/Location: The study was conducted in a hospital-based research center in Vadodara, Gujarat, India. Subjects: Eighty subjects (38 males and 42 females), with confirmed osteoarthritis (OA) (Class I-III), were randomized into two parallel groups designated as Group I (CGM-GLN) and Group II (CHN-GLN). Interventions: All the study subjects were supplemented with their corresponding intervention capsules (ether CGM along with GLN or CHN along with GLN), as a single oral dose twice a day, once in the morning 10-15 min before breakfast and again in the evening before dinner, for 84 days. Outcome measures: A validated treadmill uphill walking protocol was used for the study, and the efficiency of supplementation was evaluated using visual analogue scale (VAS) score, Karnofsky Performance Scale (KPS) score, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire at the baseline, 28th, and 84th day following the treatment. Mechanism of action of CGM-GLN combination was analyzed by measuring the levels of serum inflammatory markers interleukin 1 beta (IL-1β), interleukin 6 (IL-6), and soluble vascular cell adhesion molecule-1 (sVCAM) at the baseline and 84th day. Results: CGM-GLN was found to offer significant beneficial effects to pain, stiffness, and physical function of OA subjects compared with CHN-GLN, which was evident from the improvement in walking performance, VAS score, KPS score, and WOMAC score. The efficiency of CGM-GLN was almost double compared with the CHN-GLN by the end of the study (84th day). A significant reduction of inflammatory serum marker levels was observed among CGM-GLN subjects compared with CHN-GLN subjects. Compared with the baseline, CGM-GLN produced 54.52%, 59.08%, and 22.03% reduction in IL-1β, IL-6, and sVCAM levels, respectively. Whereas CHN-GLN group of subjects expressed only 23.17%, 21.38%, and 6.82% reduction in IL-1β, IL-6, and sVCAM levels, respectively. Conclusions: In conclusion, the present study demonstrated the potential benefits of CGM-GLN supplements in alleviating the symptoms and function of OA subjects compared with the standard CHN-GLN treatment. The augmented efficacy of CGM-GLN combination could be attributed to the enhanced anti-inflammatory effect of CGM.
Collapse
Affiliation(s)
- Aman Khanna
- Aman Hospital and Research Center, Vadodara, India
| | | | | | - Jestin V Thomas
- Leads Clinical Research & Bio Services Pvt. Ltd., Bangalore, India
| | | | - Balu Maliakel
- R&D Centre, Akay Natural Ingredients Pvt. Ltd., Cochin, India
| | | | | |
Collapse
|
|
8
|
Artuzi FE, Puricelli E, Baraldi CE, Quevedo AS, Ponzoni D. Reduction of osteoarthritis severity in the temporomandibular joint of rabbits treated with chondroitin sulfate and glucosamine. PLoS One 2020; 15:e0231734. [PMID: 32294140 PMCID: PMC7159193 DOI: 10.1371/journal.pone.0231734] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2019] [Accepted: 03/30/2020] [Indexed: 12/12/2022] Open
Abstract
Osteoarthritis is a degenerative disease that causes substantial changes in joint tissues, such as cartilage degeneration and subchondral bone sclerosis. Chondroitin sulfate and glucosamine are commonly used products for the symptomatic treatment of osteoarthritis. The aim of the present study was to investigate the effects of these products when used as structure-modifying drugs on the progression of osteoarthritis in the rabbit temporomandibular joint. Thirty-six New Zealand rabbits were divided into 3 groups (n = 12/group): control (no disease); osteoarthritis (disease induction); and treatment (disease induction and administration of chondroitin sulfate and glucosamine). Osteoarthritis was induced by intra-articular injection of monosodium iodoacetate. Animals were killed at 30 and 90 days after initiation of therapy. The treatment was effective in reducing disease severity, with late effects and changes in the concentration of glycosaminoglycans in the articular disc. The results indicate that chondroitin sulfate and glucosamine may have a structure-modifying effect on the tissues of rabbit temporomandibular joints altered by osteoarthritis.
Collapse
MESH Headings
- Animals
- Arthritis, Experimental/chemically induced
- Arthritis, Experimental/diagnosis
- Arthritis, Experimental/drug therapy
- Arthritis, Experimental/pathology
- Cartilage, Articular/cytology
- Cartilage, Articular/drug effects
- Cartilage, Articular/pathology
- Chondroitin Sulfates/administration & dosage
- Disease Models, Animal
- Drug Therapy, Combination/methods
- Extracellular Matrix/drug effects
- Extracellular Matrix/pathology
- Glucosamine/administration & dosage
- Humans
- Injections, Intra-Articular
- Injections, Subcutaneous
- Iodoacetic Acid/administration & dosage
- Iodoacetic Acid/toxicity
- Male
- Osteoarthritis/chemically induced
- Osteoarthritis/diagnosis
- Osteoarthritis/drug therapy
- Osteoarthritis/pathology
- Rabbits
- Severity of Illness Index
- Temporomandibular Joint/drug effects
- Temporomandibular Joint/pathology
Collapse
Affiliation(s)
- Felipe Ernesto Artuzi
- School of Dentistry/Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil
- * E-mail:
| | - Edela Puricelli
- Oral and Maxillofacial Surgery Unit/ Clinical Hospital of Porto Alegre (HCPA), School of Dentistry/Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil
| | - Carlos Eduardo Baraldi
- School of Dentistry/Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil
| | - Alexandre Silva Quevedo
- School of Dentistry/Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil
| | - Deise Ponzoni
- Oral and Maxillofacial Surgery Unit/ Clinical Hospital of Porto Alegre (HCPA), School of Dentistry/Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil
| |
Collapse
|
|
9
|
Wauquier F, Mevel E, Krisa S, Richard T, Valls J, Hornedo-Ortega R, Granel H, Boutin-Wittrant L, Urban N, Berger J, Descamps S, Guicheux J, Vinatier CS, Beck L, Meunier N, Blot A, Wittrant Y. Chondroprotective Properties of Human-Enriched Serum Following Polyphenol Extract Absorption: Results from an Exploratory Clinical Trial. Nutrients 2019; 11:nu11123071. [PMID: 31888255 PMCID: PMC6950735 DOI: 10.3390/nu11123071] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Revised: 12/06/2019] [Accepted: 12/12/2019] [Indexed: 02/06/2023] Open
Abstract
Polyphenols are widely acknowledged for their health benefits, especially for the prevention of inflammatory and age-related diseases. We previously demonstrated that hydroxytyrosol (HT) and procyanidins (PCy), alone or in combination, drive preventive anti-osteoathritic effects in vivo. However, the lack of sufficient clinical evidences on the relationship between dietary phytochemicals and osteoarthritis remains. In this light, we investigated in humans the potential osteoarticular benefit of a grapeseed and olive extract (OPCO) characterized for its hydroxytyrosol (HT) and procyanidins (PCy) content. We first validated, in vitro, the anti-inflammatory and chondroprotective properties of the extract on primary cultured human articular chondrocytes stimulated by interleukin-1 beta (IL-1 β). The sparing effect involved a molecular mechanism dependent on the nuclear transcription factor-kappa B (NF-κB) pathway. To confirm the clinical relevance of such a nutritional strategy, we designed an innovative clinical approach taking into account the metabolites that are formed during the digestion process and that appear in circulation after the ingestion of the OPCO extract. Blood samples from volunteers were collected following ingestion, absorption, and metabolization of the extract and then were processed and applied on human primary chondrocyte cultures. This original ex vivo methodology confirmed at a clinical level the chondroprotective properties previously observed in vitro and in vivo.
Collapse
Affiliation(s)
- Fabien Wauquier
- Clermont Auvergne University, INRA, UNH, 63000 Clermont-Ferrand, France; (F.W.); (H.G.); (L.B.-W.)
| | - Elsa Mevel
- Inserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, F-44042 Nantes, France; (E.M.); (J.G.); (C.S.V.); (L.B.)
- UFR Odontologie, Université de Nantes, F-44042 Nantes, France
| | - Stephanie Krisa
- UR Oenologie, Université de Bordeaux, ISVV, EA 4577, USC 1366 INRA, IPB4, F-33140 Villenave d’Ornon, France; (S.K.); (T.R.); (J.V.); (R.H.-O.)
| | - Tristan Richard
- UR Oenologie, Université de Bordeaux, ISVV, EA 4577, USC 1366 INRA, IPB4, F-33140 Villenave d’Ornon, France; (S.K.); (T.R.); (J.V.); (R.H.-O.)
| | - Josep Valls
- UR Oenologie, Université de Bordeaux, ISVV, EA 4577, USC 1366 INRA, IPB4, F-33140 Villenave d’Ornon, France; (S.K.); (T.R.); (J.V.); (R.H.-O.)
| | - Ruth Hornedo-Ortega
- UR Oenologie, Université de Bordeaux, ISVV, EA 4577, USC 1366 INRA, IPB4, F-33140 Villenave d’Ornon, France; (S.K.); (T.R.); (J.V.); (R.H.-O.)
| | - Henri Granel
- Clermont Auvergne University, INRA, UNH, 63000 Clermont-Ferrand, France; (F.W.); (H.G.); (L.B.-W.)
- INRAE, UMR 1019, UNH, 63122 Saint-Genès Champanelle, France
| | - Line Boutin-Wittrant
- Clermont Auvergne University, INRA, UNH, 63000 Clermont-Ferrand, France; (F.W.); (H.G.); (L.B.-W.)
| | - Nelly Urban
- Grap’sud/Inosud, 120 chemin de la regor, 30360 Cruviers-Lascours, France;
| | - Juliette Berger
- CRB Auvergne, Hématologie Biologique, Equipe d’Accueil 7453 CHELTER, CHU Estaing, 1 place Lucie et Raymond Aubrac, F-63003 Clermont-Ferrand, France;
| | - Stéphane Descamps
- Orthopedics department, University Hospital Clermont-Ferrand, F-63003 Clermont-Ferrand, France;
| | - Jérôme Guicheux
- Inserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, F-44042 Nantes, France; (E.M.); (J.G.); (C.S.V.); (L.B.)
- UFR Odontologie, Université de Nantes, F-44042 Nantes, France
- Rhumatology department, CHU Nantes, PHU4 OTONN, F-44042 Nantes, France
| | - Claire S. Vinatier
- Inserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, F-44042 Nantes, France; (E.M.); (J.G.); (C.S.V.); (L.B.)
- UFR Odontologie, Université de Nantes, F-44042 Nantes, France
- Rhumatology department, CHU Nantes, PHU4 OTONN, F-44042 Nantes, France
| | - Laurent Beck
- Inserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, F-44042 Nantes, France; (E.M.); (J.G.); (C.S.V.); (L.B.)
- UFR Odontologie, Université de Nantes, F-44042 Nantes, France
- Rhumatology department, CHU Nantes, PHU4 OTONN, F-44042 Nantes, France
| | - Nathalie Meunier
- CHU Clermont-Ferrand, Centre de Recherche en Nutrition Humaine Auvergne, 58 rue Montalembert, F-63000 Clermont-Ferrand, France; (N.M.); (A.B.)
| | - Adeline Blot
- CHU Clermont-Ferrand, Centre de Recherche en Nutrition Humaine Auvergne, 58 rue Montalembert, F-63000 Clermont-Ferrand, France; (N.M.); (A.B.)
| | - Yohann Wittrant
- Clermont Auvergne University, INRA, UNH, 63000 Clermont-Ferrand, France; (F.W.); (H.G.); (L.B.-W.)
- INRAE, UMR 1019, UNH, 63122 Saint-Genès Champanelle, France
- Correspondence: ; Tel.: +33-(0)6-8229-7271
| |
Collapse
|
|
10
|
Karakurt I, Ozaltin K, Vesela D, Lehocky M, Humpolíček P, Mozetič M. Antibacterial Activity and Cytotoxicity of Immobilized Glucosamine/Chondroitin Sulfate on Polylactic Acid Films. Polymers (Basel) 2019; 11:E1186. [PMID: 31311162 PMCID: PMC6680945 DOI: 10.3390/polym11071186] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2019] [Revised: 07/07/2019] [Accepted: 07/12/2019] [Indexed: 12/11/2022] Open
Abstract
Polylactic acid (PLA) is one of the most produced polymeric materials, due to its exceptional chemical and mechanical properties. Some of them, such as biodegradability and biocompatibility, make them attractive for biomedical applications. Conversely, the major drawback of PLA in the biomedical field is their vulnerability to bacterial contamination. This study focuses on the immobilization of saccharides onto the PLA surface by a multistep approach, with the aim of providing antibacterial features and evaluting the synergistic effect of these saccharides. In this approach, after poly (acrylic acid) (PAA) brushes attached non-covalently to the PLA surface via plasma post-irradiation grafting technique, immobilization of glucosamine (GlcN) and chondroitin sulfate (ChS) to the PAA brushes was carried out. To understand the changes in surface properties, such as chemical composition, surface topography and hydrophilicity, the untreated and treated PLA films were analyzed using various characterization techniques (contact angle, scanning electron microscopy, X-ray photoelectron spectroscopy). In vitro cytotoxicity assays were investigated by the methyl tetrazolium test. The antibacterial activity of the PLA samples was tested against Escherichia coli and Staphylococcus aureus bacteria strains. Plasma-treated films immobilized with ChS and GlcN, separately and in combination, demonstrated bactericidal effect against the both bacteria strains and also the results revealed that the combination has no synergistic effect on antibacterial action.
Collapse
Affiliation(s)
- Ilkay Karakurt
- Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Nam. T.G.M. 5555, 76001 Zlín, Czech Republic
| | - Kadir Ozaltin
- Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Nam. T.G.M. 5555, 76001 Zlín, Czech Republic
| | - Daniela Vesela
- Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Nam. T.G.M. 5555, 76001 Zlín, Czech Republic
| | - Marian Lehocky
- Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Nam. T.G.M. 5555, 76001 Zlín, Czech Republic.
- Faculty of Technology, Tomas Bata University in Zlín, Vavreckova 275, 76001 Zlín, Czech Republic.
| | - Petr Humpolíček
- Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Nam. T.G.M. 5555, 76001 Zlín, Czech Republic
- Faculty of Technology, Tomas Bata University in Zlín, Vavreckova 275, 76001 Zlín, Czech Republic
| | - Miran Mozetič
- Department of Surface Engineering, Jozef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia
| |
Collapse
|
|
11
|
Bian L, Liu C, Chen S, Zhao F, Ge J, Tan J. Transcriptome analysis of gene expression patterns during embryonic development in golden cuttlefish (Sepia esculenta). Genes Genomics 2018; 40:253-263. [PMID: 29892796 DOI: 10.1007/s13258-017-0588-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Accepted: 06/22/2017] [Indexed: 11/28/2022]
Abstract
Golden cuttlefish (Sepia esculenta) is an important economic species in China. Because of the rapid decline of its natural resource, researchers are exploring breeding technique for this species. The major obstacle that hinders artificial breeding of S. esculenta is the low larvae survival rate. Mortality is especially high during the mouth-opening stage. Investigating the embryogenesis before the first feed could provide theoretical guidance for reproduction control and breeding of S. esculenta and other Sepia species. In this study, we analyzed the dynamics of the S. esculenta transcriptome along different stages of embryonic development by mRNA-sEq. Our bioinformatics protocol identified 1492 differentially expressed genes (DEGs) across the early developmental stages. Gene ontology enrichment analysis showed that the DEGs were significantly involved in developmental processes and molecular functions, including chitin metabolic process, peptidase activity, catalytic activity, and calcium ion binding. Our results indicated that genes related to cuttlebone development and gene regulation functions were active during the early life phase of S. esculenta. Hierarchical clustering of the DEGs reflected the successiveness of the developmental stages, revealing that gene expression patterns of neighboring stages were similar. The DEG analysis allowed us to identify specific genes and relevant biological pathways to better understand the molecular mechanisms during each developmental stage. This study provides novel insights into the processes underlying the early developmental stages of S. esculenta. The transcriptomic data and identified genes will serve as valuable references for the developmental biology of this species and will help promote its aquaculture research.
Collapse
Affiliation(s)
- Li Bian
- Key Laboratory for Sustainable Utilization of Marine Fisheries Resources, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Nanjing road 106, Qingdao, Shandong, China
| | - Changlin Liu
- Key Laboratory for Sustainable Utilization of Marine Fisheries Resources, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Nanjing road 106, Qingdao, Shandong, China.
| | - Siqing Chen
- Key Laboratory for Sustainable Utilization of Marine Fisheries Resources, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Nanjing road 106, Qingdao, Shandong, China
| | - Fazhen Zhao
- Key Laboratory for Sustainable Utilization of Marine Fisheries Resources, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Nanjing road 106, Qingdao, Shandong, China
| | - Jianlong Ge
- Key Laboratory for Sustainable Utilization of Marine Fisheries Resources, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Nanjing road 106, Qingdao, Shandong, China
| | - Jie Tan
- Key Laboratory for Sustainable Utilization of Marine Fisheries Resources, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Nanjing road 106, Qingdao, Shandong, China
| |
Collapse
|
|
12
|
Jeong DH, Ullah HMA, Goo MJ, Ghim SG, Hong IH, Kim AY, Jeon SM, Choi MS, Elfadl AK, Chung MJ, Lee EJ, Kim YD, Kim JH, Kim SY, Jeong KS. Effects of oral glucosamine hydrochloride and mucopolysaccharide protein in a rabbit model of osteoarthritis. Int J Rheum Dis 2017; 21:620-628. [PMID: 29205898 DOI: 10.1111/1756-185x.13239] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
AIM The aim was to study whether oral glucosamine hydrochloride (GlcN.HCl) or mucopolysaccharide protein (MucoP) has a structure-modifying effect on an anterior cruciate ligament transection (ACLT) rabbit model of osteoarthritis (OA). METHODS OA was surgically induced in the right knees of rabbits by transection of the ACLT. The left knees served as a sham-operated control. The animals were divided into four groups (n = 6 each): negative control (phosphate buffered saline, orally), positive control (oral celecoxib 10 mg/kg body weight/day), GlcN.HCl (oral 100 mg/kg/day) and MucoP (oral 100 mg/kg/day). Experimental animals were sacrificed after 8 weeks of treatment and the distal femur was removed for macroscopic examination, histological assessment, and terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) assay of the OA rabbits. RESULTS On gross morphology, severe lesions were observed in articular cartilage in the negative control group. In the GlcN.HCl and MucoP treatment groups, fibrillations and cartilaginous lesions were significantly (P < 0.05) decreased compared to the negative control group. In particular, degenerative changes in cartilage and chondrocyte cellularity were significantly reduced (P < 0.05) in the positive control (celecoxib) group, GlcN.HCl treatment group and MucoP treatment group compared with the negative control group. TUNEL assay showed that apoptotic chondrocytes were significantly suppressed in the celecoxib group. Similar significant (P < 0.05) results were seen in the GlcN.HCl group and MucoP group but apoptosis of chondrocytes were high in the negative control group. CONCLUSION These data suggest that the protective effects of GlcN.HCl and MucoP may play a useful role in the clinical treatment of OA.
Collapse
Affiliation(s)
- Da-Hee Jeong
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - H M Arif Ullah
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Moon-Jung Goo
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Soong-Gu Ghim
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Il-Hwa Hong
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Ah-Young Kim
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Sun-Min Jeon
- Department of Food Science and Nutrition, Kyungpook National University, Daegu, Korea
| | - Myung-Sook Choi
- Department of Food Science and Nutrition, Kyungpook National University, Daegu, Korea
| | - Ahmed K Elfadl
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Myung-Jin Chung
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Eun-Joo Lee
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Yong D Kim
- Department of Pathology, Kyungpook National University, Daegu, Korea
| | - Jun-Hyung Kim
- Department of Orthopedic Surgery, Kyungpook National University, Daegu, Korea
| | - Shin-Yoon Kim
- Department of Orthopedic Surgery, Kyungpook National University, Daegu, Korea
| | - Kyu-Shik Jeong
- Department of Pathology, Kyungpook National University, Daegu, Korea
| |
Collapse
|
|
13
|
Roman-Blas JA, Mediero A, Tardío L, Portal-Nuñez S, Gratal P, Herrero-Beaumont G, Largo R. The combined therapy with chondroitin sulfate plus glucosamine sulfate or chondroitin sulfate plus glucosamine hydrochloride does not improve joint damage in an experimental model of knee osteoarthritis in rabbits. Eur J Pharmacol 2016; 794:8-14. [PMID: 27845067 DOI: 10.1016/j.ejphar.2016.11.015] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2016] [Revised: 11/08/2016] [Accepted: 11/09/2016] [Indexed: 01/15/2023]
Abstract
Osteoarthritis is the most common chronic joint disorder especially during aging. Although with controversies, glucosamine, both in its forms of sulfate and hydrochloride, and chondroitin sulfate are commonly employed to treat osteoarthritis. Due to the modest improve in the symptoms observed in patients treated with these drugs alone, a formulation combining both agents has been considered. The discrepant results achieved for pain control or structural improvement in osteoarthritis patients has been attributed to the quality of chemical formulations or different bias in clinical studies. The current study has been designed to test the effects of two different combined formulations with adequate pharmaceutical grade of these drugs in osteoarthritic joints, and to explore the underlying mechanisms modulated by both formulations in different osteoarthritis target tissues. Knee osteoarthritis was surgically induced in experimental rabbits. Some animals received the combined therapy (CT)1, (chondroitin sulfate 1200mg/day + glucosamine sulfate 1500mg/day), or the CT2 ((chondroitin sulfate 1200mg/day + glucosamine hydrochloride 1500mg/day). Neither CT1 nor CT2 significantly modified the cartilage damage or the synovial inflammation observed in osteoarthritic animals. Treatments were also unable to modify the presence of pro-inflammatory mediators, and the synthesis of metalloproteinases in the cartilage or in the synovium of osteoarthritic animals. Combined therapies did not modify the decrease in the subchondral bone mineral density observed in osteoarthritic rabbits. Therapies of chondroitin sulfate plus glucosamine sulfate or chondroitin sulfate plus glucosamine hydrochloride failed to improve structural damage or to ameliorate the inflammatory profile of joint tissues during experimental osteoarthritis.
Collapse
Affiliation(s)
- Jorge A Roman-Blas
- Bone and Joint Research Unit. IIS-Fundación Jiménez Díaz UAM and Cooperative Research Thematic Network on Aging and Frailty (RETICEF), Madrid, Spain.
| | - Aránzazu Mediero
- Bone and Joint Research Unit. IIS-Fundación Jiménez Díaz UAM and Cooperative Research Thematic Network on Aging and Frailty (RETICEF), Madrid, Spain.
| | - Lidia Tardío
- Bone and Joint Research Unit. IIS-Fundación Jiménez Díaz UAM and Cooperative Research Thematic Network on Aging and Frailty (RETICEF), Madrid, Spain.
| | - Sergio Portal-Nuñez
- Bone and Joint Research Unit. IIS-Fundación Jiménez Díaz UAM and Cooperative Research Thematic Network on Aging and Frailty (RETICEF), Madrid, Spain.
| | - Paula Gratal
- Bone and Joint Research Unit. IIS-Fundación Jiménez Díaz UAM and Cooperative Research Thematic Network on Aging and Frailty (RETICEF), Madrid, Spain.
| | - Gabriel Herrero-Beaumont
- Bone and Joint Research Unit. IIS-Fundación Jiménez Díaz UAM and Cooperative Research Thematic Network on Aging and Frailty (RETICEF), Madrid, Spain.
| | - Raquel Largo
- Bone and Joint Research Unit. IIS-Fundación Jiménez Díaz UAM and Cooperative Research Thematic Network on Aging and Frailty (RETICEF), Madrid, Spain.
| |
Collapse
|
|
14
|
Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption. Sci Rep 2016; 6:33527. [PMID: 27640363 PMCID: PMC5027597 DOI: 10.1038/srep33527] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2016] [Accepted: 08/26/2016] [Indexed: 12/24/2022] Open
Abstract
Polyphenols exert a large range of beneficial effects in the prevention of age-related diseases. We sought to determine whether an extract of olive and grape seed standardized according to hydroxytyrosol (HT) and procyanidins (PCy) content, exerts preventive anti-osteoathritic effects. To this aim, we evaluated whether the HT/PCy mix could (i) have in vitro anti-inflammatory and chondroprotective actions, (ii) exert anti-osteoarthritis effects in two post-traumatic animal models and (iii) retain its bioactivity after oral administration. Anti-inflammatory and chondroprotective actions of HT/PCy were tested on primary cultured rabbit chondrocytes stimulated by interleukin-1 beta (IL-1β). The results showed that HT/PCy exerts anti-inflammatory and chondroprotective actions in vitro. The preventive effect of HT/PCy association was assessed in two animal models of post-traumatic OA in mice and rabbits. Diet supplementation with HT/PCy significantly decreased the severity of post-traumatic osteoarthritis in two complementary mice and rabbit models. The bioavailability and bioactivity was evaluated following gavage with HT/PCy in rabbits. Regular metabolites from HT/PCy extract were found in sera from rabbits following oral intake. Finally, sera from rabbits force-fed with HT/PCy conserved anti-IL-1β effect, suggesting the bioactivity of this extract. To conclude, HT/PCy extract may be of clinical significance for the preventive treatment of osteoarthritis.
Collapse
|
|
15
|
Xue J, Song W, Yao H, Hou S, Liu S, Wang Y, Pei D, Zhu X, Qin D, Ren L. Effects of cholic acid modified glucosamine on chondrogenic differentiation. RSC Adv 2016. [DOI: 10.1039/c6ra09547j] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Glucosamine hydrochloride is a widely used drug for the treatment of osteoarthritis and can be easily modified by other molecules because of its alterable functional groups.
Collapse
|